Stereotactic Body Radiotherapy for Early Stage Lung Cancer

Stereotactic body radiation therapy (SBRT) is a newly developed technique currently in clinical use. SBRT originated from stereotactic radiosurgery for intracranial tumors. SBRT has been widely used clinically for lung cancer. The practice of SBRT demands different kinds of patient fixation, breathi...

Descripción completa

Detalles Bibliográficos
Autor principal: Nagata, Yasushi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Cancer Association 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804726/
https://www.ncbi.nlm.nih.gov/pubmed/24155673
http://dx.doi.org/10.4143/crt.2013.45.3.155
_version_ 1782288201647390720
author Nagata, Yasushi
author_facet Nagata, Yasushi
author_sort Nagata, Yasushi
collection PubMed
description Stereotactic body radiation therapy (SBRT) is a newly developed technique currently in clinical use. SBRT originated from stereotactic radiosurgery for intracranial tumors. SBRT has been widely used clinically for lung cancer. The practice of SBRT demands different kinds of patient fixation, breathing control, target determination, treatment planning, and verifications. The history and current standard technique are reviewed. Clinical studies of lung cancer showed high local control rates with acceptable toxicities. Past and on-going clinical trials are reviewed.
format Online
Article
Text
id pubmed-3804726
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Korean Cancer Association
record_format MEDLINE/PubMed
spelling pubmed-38047262013-10-23 Stereotactic Body Radiotherapy for Early Stage Lung Cancer Nagata, Yasushi Cancer Res Treat Review Article Stereotactic body radiation therapy (SBRT) is a newly developed technique currently in clinical use. SBRT originated from stereotactic radiosurgery for intracranial tumors. SBRT has been widely used clinically for lung cancer. The practice of SBRT demands different kinds of patient fixation, breathing control, target determination, treatment planning, and verifications. The history and current standard technique are reviewed. Clinical studies of lung cancer showed high local control rates with acceptable toxicities. Past and on-going clinical trials are reviewed. Korean Cancer Association 2013-09 2013-09-30 /pmc/articles/PMC3804726/ /pubmed/24155673 http://dx.doi.org/10.4143/crt.2013.45.3.155 Text en Copyright © 2013 by the Korean Cancer Association http://creativecommons.org/licenses/by-nc/3.0/ This is an Open-Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review Article
Nagata, Yasushi
Stereotactic Body Radiotherapy for Early Stage Lung Cancer
title Stereotactic Body Radiotherapy for Early Stage Lung Cancer
title_full Stereotactic Body Radiotherapy for Early Stage Lung Cancer
title_fullStr Stereotactic Body Radiotherapy for Early Stage Lung Cancer
title_full_unstemmed Stereotactic Body Radiotherapy for Early Stage Lung Cancer
title_short Stereotactic Body Radiotherapy for Early Stage Lung Cancer
title_sort stereotactic body radiotherapy for early stage lung cancer
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3804726/
https://www.ncbi.nlm.nih.gov/pubmed/24155673
http://dx.doi.org/10.4143/crt.2013.45.3.155
work_keys_str_mv AT nagatayasushi stereotacticbodyradiotherapyforearlystagelungcancer

Ejemplares similares